Indian Pharma Market Continues Single-Digit Growth In August

New Delhi : The Indian pharmaceutical sector reported single-digit growth in August for the fourth consecutive month due to a high base and challenges in volume growth.

Industry sales were up 5.1% in comparison with 12.1% over the same period last year, according to data from All Indian Origin Chemists and Distributors Ltd. Sales had risen 5.3% in July, 6% in June, and 5.6% in May.

The mid-single-digit performance is partly due to robust growth in August 2022 and challenges in volume growth, which has been “negative since the past five months”, said Krishnanath Munde, associate director at India Ratings and Research Pvt.

Growth in new product launches has shown consistent improvement in recent months, with price growth being stable at around 5–6%, Munde told BQ Prime. “India Ratings maintains its Indian pharma market growth estimates for FY24 at 10–11% year-on-year.”

Key Highlights

  • Volume declined 3.3% versus a 4% rise last year.
  • Prices increased 5.1% year-on-year as compared with 6.6% last year.
  • New product launches registered a growth of 3.3% against a rise of 1.5% over the previous year.

On a January–August basis, growth in the average price and new products was 5.5% and 3.2%, respectively, while volume growth contracted 1.6%.

Overall, the average Indian pharma market growth remained healthy at 7.1% year-on-year, according to Munde.

Related Posts

  • Pharma
  • May 29, 2024
  • 25 views
Delhi Police Busts Major Illegal Alprazolam Manufacturing Racket

New Delhi: The Delhi Police Special Cell has arrested two men allegedly involved in the illegal manufacturing of the psychotropic substance Alprazolam in UP’s Gajraula, an officer on Tuesday said. The…

  • Pharma
  • May 28, 2024
  • 75 views
Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

New Delhi:  Animal healthcare solutions provider Ajooni Biotech is expecting additional annual revenue of Rs 200 crore from commercial production of moringa by financial year 2025-26. The leading animal feed…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Police Busts Major Illegal Alprazolam Manufacturing Racket

Delhi Police Busts Major Illegal Alprazolam Manufacturing Racket

Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results

BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results

Human Milk Siphoned Off From Banks To Industries

Human Milk Siphoned Off From Banks To Industries

DoP Launches Portal And Constitutes ICPMR For Implementation Of R&D Policy

DoP Launches Portal And Constitutes ICPMR For Implementation Of R&D Policy

NPPA Rejects Forms To Fix Retail Price For Formulations Manufactured In Synokem’s Facility

NPPA Rejects Forms To Fix Retail Price For Formulations Manufactured In Synokem’s Facility